SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003433
Filing Date
2020-03-05
Accepted
2020-03-05 15:37:27
Documents
69
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1148840
2 ex4-10.htm EX-4.10 24878
3 ex10-39.htm EX-10.39 19599
4 ex31-1.htm EX-31.1 12244
5 ex31-2.htm EX-31.2 11511
6 ex32.htm EX-32 6428
  Complete submission text file 0001493152-20-003433.txt   4451663

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pvct-20191231.xml EX-101.INS 670154
8 XBRL SCHEMA FILE pvct-20191231.xsd EX-101.SCH 48250
9 XBRL CALCULATION FILE pvct-20191231_cal.xml EX-101.CAL 57764
10 XBRL DEFINITION FILE pvct-20191231_def.xml EX-101.DEF 187679
11 XBRL LABEL FILE pvct-20191231_lab.xml EX-101.LAB 346260
12 XBRL PRESENTATION FILE pvct-20191231_pre.xml EX-101.PRE 279128
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36457 | Film No.: 20690644
SIC: 2834 Pharmaceutical Preparations